CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong
· Delayed Price · Currency is HKD 0.8900
+0.0500 (5.95%)
Jun 4, 2025, 2:44 PM HKT
HKG:0775 Revenue
In the year 2024, CK Life Sciences Int'l., (Holdings) had annual revenue of 5.52B HKD with 3.76% growth. CK Life Sciences Int'l., (Holdings) had revenue of 2.89B in the half year ending December 31, 2024, with 5.55% growth.
Revenue
5.52B
Revenue Growth
+3.76%
P/S Ratio
1.46
Revenue / Employee
2.72M
Employees
2,033
Market Cap
8.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.52B | 199.94M | 3.76% |
| Dec 31, 2023 | 5.32B | 47.14M | 0.89% |
| Dec 31, 2022 | 5.28B | -126.72M | -2.35% |
| Dec 31, 2021 | 5.40B | 459.77M | 9.30% |
| Dec 31, 2020 | 4.94B | -24.48M | -0.49% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |
CK Life Sciences Int'l., (Holdings) News
- 8 months ago - CK Life’s new CEO counts on Big Pharma experience to boost new drug success, earnings - South China Morning Post